Aura Biosciences, Inc.

AURA · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$87-$76-$59-$35
Dep. & Amort.$1$1$1$1
Deferred Tax$0$0$0$0
Stock-Based Comp.$12$9$6$2
Change in WC-$3$4-$3-$0
Other Non-Cash-$3-$2-$0$0
Operating Cash Flow-$80-$64-$55-$32
Investing Activities
PP&E Inv.-$1-$1-$1-$2
Net Acquisitions$0$0$0$0
Inv. Purchases-$59-$234-$120$0
Inv. Sales/Matur.$129$120$53$0
Other Inv. Act.$0$0-$0$0
Investing Cash Flow$69-$114-$68-$2
Financing Activities
Debt Repay.$0$0$0$0
Stock Issued$2$3$9$79
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$0$94$87$88
Financing Cash Flow$2$97$96$166
Forex Effect$0$0$0$0
Net Chg. in Cash-$9-$81-$27$132
Supplemental Information
Beg. Cash$42$122$149$17
End Cash$32$42$122$149
Free Cash Flow-$81-$65-$56-$35
Aura Biosciences, Inc. (AURA) Financial Statements & Key Stats | AlphaPilot